If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

  • There is currently no data for ACID

To Accept Nominations for Directors

28 Mar 2014 11:54

RNS Number : 4632D
Acer Incorporated
28 March 2014
 



Subject:

To Accept Nominations for Acer Directors and Independent Directors

Statutory Basement:

Subject to Article 192-1 and 216-1 of the Company Law, and under the resolution of BOD meeting held on 27th March, 2014

GSM Date:

Acer's General Shareholders' Meeting will be held on 18th June, 2014

Qualification:

Any shareholder holding 1 % or more of the total outstanding shares of the Company may submit to the company in writing of a list of Director/Independent director candidates

Numbers to be elected:

It's proposed to elect 9 Directors (including 3 Independent Directors).

The candidates shall be ruled out while (i.) providing the total number of candidates exceed the seats for Director/Independent director or (ii.) the nominee's qualification does not comply with the regulatory requirements

Open period:

Started from 2nd April to 11th April, 2014

Place of Submission Received:

Shareholders Service Department of Acer where at 7F-5, 369, Fuxing N. Rd., Songshan Dist., 105, Taipei, Taiwan

References:

The list of candidates submitted by the shareholders should be annexed with the name, education background, work experience of the candidate, a letter of undertaking signed by the candidate indicating his or her consent to serve as Director/Independent director if elected, a written statement signed by the candidate declaring that he or she is not under any of the circumstances set forth in Article 30 of the Company Law, and other supporting documents provided by the candidate; and the registration documentation of the juristic person and the certification of shareholdings shall be included as well while the juristic person as shareholder or its authorized representative be nominated as the candidates.

The nominee may, whose relevant supporting documents as required above are not attached to the list, be removed from the candidates list.

Others:

The nominations for Director/Independent Director will be received during 9:00 am to 5:00 pm, from 2nd April to 11th April, 2014. Any shareholder who intends to nominate shall present the application and the contact information no later than 5:00 pm, 11th April 2014 for the BOD to review and to notify the consequence.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQKFDPDBKDBNB
Date   Source Headline
27th Jun 201810:59 amRNSAcer is to Attend UBS Taiwan Conference 2018
22nd Jun 201810:36 amRNSAcer shareholders to subscribe StarVR's new shares
15th Jun 201811:35 amRNSTo announce the Ex-dividend record date
15th Jun 201811:31 amRNSMaterial resolutions of the Company's 2018 GSM
12th Jun 20182:47 pmRNSTo adjust announcement of derivative instrument
7th Jun 20182:36 pmRNSUn-Audited Monthly Sales Ended May 31, 2018
29th May 20187:00 amRNS2018 Shareholders Meeting Information
22nd May 201810:12 amRNSAcer to Host Its Investor Conference
14th May 201810:13 amRNSTo Attend Fubon & Jefferies Taiwan Corporate Day
14th May 201810:13 amRNSAcer is to Attend Waterland Investment Forum 2018
10th May 20189:51 amRNSAcer Consolidated Financial Statements
9th May 201810:57 amRNSAcer announces 2018 Q1 consolidated results
8th May 201811:59 amRNSUn-Audited Monthly Sales Ended April 30, 2018
8th May 20187:00 amRNSAnnouncement on behalf of subsidiary ACCSI
8th May 20187:00 amRNSAnnouncement on behalf of subsidiary ITS
13th Apr 201810:55 amRNSThe Company's Acting Spokesperson Change
9th Apr 201811:31 amRNSUn-Audited Monthly Sales Ended March 31, 2018
21st Mar 201810:17 amRNSAcer announces FY 2017 results
21st Mar 201810:12 amRNSAcer BOD Approved to Convene the 2018 GSM
21st Mar 201810:11 amRNSAcer BOD resolved to distribute dividends
13th Mar 201810:01 amRNSAcer is to Attend 2018 Asia Pacific TMT Conference
9th Mar 20187:04 amRNSUn-Audited Monthly Sales Ended February 28, 2018
8th Feb 20188:09 amRNSUn-Audited Monthly Sales Ended January 31, 2018
9th Jan 20188:20 amRNSUn-Audited Monthly Sales Ended December 31, 2017
4th Jan 20189:32 amRNSDisclosure on behalf of Acer Subsidiary, ACCQ
3rd Jan 20189:01 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
29th Dec 201712:46 pmRNSSecond Price Monitoring Extn
29th Dec 201712:41 pmRNSPrice Monitoring Extension
27th Dec 20177:00 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
27th Dec 20177:00 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
15th Dec 20179:11 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
15th Dec 20179:10 amRNSDisclosure on behalf of Acer Subsidiary, AAH
12th Dec 20179:39 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
8th Dec 20177:00 amRNSUn-Audited Monthly Sales Ended November 30, 2017
29th Nov 20179:02 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
28th Nov 20179:11 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
24th Nov 20179:06 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
24th Nov 20178:48 amRNSAnnouncement In Accordance with Taiwan Regulation
20th Nov 20173:46 pmRNSSecond Price Monitoring Extn
20th Nov 20173:41 pmRNSPrice Monitoring Extension
20th Nov 20177:28 amRNSPer TWSE's request to make announcement
13th Nov 20179:14 amRNSDisclosure on behalf of Acer Subsidiary, ACCN
9th Nov 20179:09 amRNSAcer makes a donation to Acer Foundation
9th Nov 20179:07 amRNSAcer participates in AOPEN's private placement
9th Nov 20179:05 amRNSAnnouncement on behalf of subsidiary ITS
9th Nov 20179:01 amRNSAnnouncement on behalf of subsidiary ACCSI
9th Nov 20178:58 amRNSUn-audited sales revenue ended Oct. 31 2017
9th Nov 20178:58 amRNSAcer BoD approved 2017 Q3 consolidated results
26th Oct 20179:02 amRNSDisclosure on behalf of Acer's Subsidiary, ACCN
24th Oct 201710:02 amRNSDisclosure on behalf of Acer's Subsidiary, ACCN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.